Scholarlink

Background <p>Frailty is common among patients undergoing maintenance haemodialysis (MHD) and is linked to multiple adverse outcomes, including increased mortality. However, large-scale cohort studies in China on the associations between frailty and major adverse cardiovascular events (MACE) as well as all-cause mortality in patients undergoing haemodialysis are lacking. This study aimed to investigate the associations between frailty and MACE and all-cause mortality in this population.</p> Methods <p>This single-centre retrospective cohort study enrolled patients on haemodialysis at the First Affiliated Hospital, Zhejiang University School of Medicine, from August 2020 to December 2021, with follow-up until August 31, 2025. Frailty status was assessed using the Fried Frailty Scale. Endpoints included the occurrence of all-cause mortality and MACE. A competing risk model was used to examine the associations between frailty and both MACE and all-cause mortality. Additionally, multidimensional sensitivity analyses were performed to assess the robustness of the findings.</p> Results <p>This study encompassed a cohort of 810 patients undergoing maintenance haemodialysis (MHD). The cumulative incidence of major adverse cardiovascular events (MACE) over five years was 33.0% (95% CI: 26.1–39.8%), while the cumulative incidence of all-cause mortality was 61.0% (95% CI: 53.4–68.7%). Both incidences were significantly elevated in the frail patient group compared to their non-frail counterparts (<i>P</i> &lt; 0.001). Following multivariable adjustment, the Fine–Gray competing risk model revealed that frail patients exhibited a 4.96-fold increased risk of MACE (95% CI: 2.50–9.85; <i>P</i> &lt; 0.001) and a 3.35-fold increased risk of all-cause mortality (95% CI: 2.10–5.35; <i>P</i> &lt; 0.001), underscoring a significant positive association. Sensitivity analyses corroborated that frailty remained significantly associated with both MACE and all-cause mortality.</p> Conclusion <p>Frailty demonstrated a significant correlation with an increased risk of MACE and all-cause mortality in patients undergoing MHD, with the risk escalating in a linear manner in accordance with the severity of frailty.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Association between frailty and MACE and all-cause mortality in Chinese maintenance haemodialysis patients: a retrospective cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月25日

查看全文
  • Jinping Ying,
  • Linglin Chen,
  • Jia Liang,
  • Liuqian Zhang,
  • Junshuang Ye,
  • Huimin Bao,
  • Jiayu Zhu,
  • Yujiao Zhang,
  • Genlian Cai,
  • Ping Zhang

摘要

Background

Frailty is common among patients undergoing maintenance haemodialysis (MHD) and is linked to multiple adverse outcomes, including increased mortality. However, large-scale cohort studies in China on the associations between frailty and major adverse cardiovascular events (MACE) as well as all-cause mortality in patients undergoing haemodialysis are lacking. This study aimed to investigate the associations between frailty and MACE and all-cause mortality in this population.

Methods

This single-centre retrospective cohort study enrolled patients on haemodialysis at the First Affiliated Hospital, Zhejiang University School of Medicine, from August 2020 to December 2021, with follow-up until August 31, 2025. Frailty status was assessed using the Fried Frailty Scale. Endpoints included the occurrence of all-cause mortality and MACE. A competing risk model was used to examine the associations between frailty and both MACE and all-cause mortality. Additionally, multidimensional sensitivity analyses were performed to assess the robustness of the findings.

Results

This study encompassed a cohort of 810 patients undergoing maintenance haemodialysis (MHD). The cumulative incidence of major adverse cardiovascular events (MACE) over five years was 33.0% (95% CI: 26.1–39.8%), while the cumulative incidence of all-cause mortality was 61.0% (95% CI: 53.4–68.7%). Both incidences were significantly elevated in the frail patient group compared to their non-frail counterparts (P < 0.001). Following multivariable adjustment, the Fine–Gray competing risk model revealed that frail patients exhibited a 4.96-fold increased risk of MACE (95% CI: 2.50–9.85; P < 0.001) and a 3.35-fold increased risk of all-cause mortality (95% CI: 2.10–5.35; P < 0.001), underscoring a significant positive association. Sensitivity analyses corroborated that frailty remained significantly associated with both MACE and all-cause mortality.

Conclusion

Frailty demonstrated a significant correlation with an increased risk of MACE and all-cause mortality in patients undergoing MHD, with the risk escalating in a linear manner in accordance with the severity of frailty.